Explore Products

My Quote Request

No products added yet

6505-01-356-3850

20 Products

NDC51672-1309-01

BETAMETHASONE DIPRO

NSN, MFG P/N

6505013563850

NSN

6505-01-356-3850

View More Info

NDC51672-1309-01

BETAMETHASONE DIPRO

NSN, MFG P/N

6505013563850

NSN

6505-01-356-3850

MFG

TARO PHARMACEUTICALS USA INC

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: EQUIVALENT TO 0.05% BETAMETHASONE,USP IN AN AUGMENTED WATER IN OIL EMOLLIENT GEL BASE; EQUIV TO 0.5 MG BETAMETHASONE PER GM OF GEL IN AUGMENTED GEL BASE OF PURIFIED WATER,PROPYLENE GLYCOL,CARBOMER 940,AND SODIUM HYDROXIDE; 15 GM; THERAPEUTICALLY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAMETHASONE DIPROPIONATE GEL 15GM TUBE
~1: EQUIVALENT TO SCHERING

F92A626

METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505013560253

NSN

6505-01-356-0253

View More Info

F92A626

METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505013560253

NSN

6505-01-356-0253

MFG

AIR FORCE MEDICAL LOGISTICS OFFICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METHYLPHENIDATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPHENIDATE HYDROCHLORIDE TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00083-0034-30

METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505013560253

NSN

6505-01-356-0253

View More Info

NDC00083-0034-30

METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505013560253

NSN

6505-01-356-0253

MFG

CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METHYLPHENIDATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPHENIDATE HYDROCHLORIDE TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

RITALIN

METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505013560253

NSN

6505-01-356-0253

View More Info

RITALIN

METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505013560253

NSN

6505-01-356-0253

MFG

CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METHYLPHENIDATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPHENIDATE HYDROCHLORIDE TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

272-28

WATER,PURIFIED,USP

NSN, MFG P/N

6505013560886

NSN

6505-01-356-0886

View More Info

272-28

WATER,PURIFIED,USP

NSN, MFG P/N

6505013560886

NSN

6505-01-356-0886

MFG

HACH COMPANY DBA HYDROLAB INSTRUMENTS

Description

SPECIFICATION/STANDARD DATA: 91224-272-28 MANUFACTURERS STANDARD

FLUDARA

FLUDARABINE PHOSPHATE FOR INJECTION

NSN, MFG P/N

6505013561191

NSN

6505-01-356-1191

View More Info

FLUDARA

FLUDARABINE PHOSPHATE FOR INJECTION

NSN, MFG P/N

6505013561191

NSN

6505-01-356-1191

MFG

BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS FLUDARABINE PHOSPHATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUDARABINE PHOSPHATE FOR INJECTION 50MG VIAL 5S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 5

NDC50419-0511-06

FLUDARABINE PHOSPHATE FOR INJECTION

NSN, MFG P/N

6505013561191

NSN

6505-01-356-1191

View More Info

NDC50419-0511-06

FLUDARABINE PHOSPHATE FOR INJECTION

NSN, MFG P/N

6505013561191

NSN

6505-01-356-1191

MFG

BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS FLUDARABINE PHOSPHATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUDARABINE PHOSPHATE FOR INJECTION 50MG VIAL 5S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 5

1950-31

DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE,ADSORBED,MODIFIED

NSN, MFG P/N

6505013561193

NSN

6505-01-356-1193

View More Info

1950-31

DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE,ADSORBED,MODIFIED

NSN, MFG P/N

6505013561193

NSN

6505-01-356-1193

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPHTHERIA & TETANUS TOXOIDS & PERTUSSIS VACCINE ABSORBED MOD 5ML
IMMEDIATE CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: CONTAINS 7.5 LF OF DIPHTHERIA TOXOID AND 5.0 LF OF TETANUS TOXOID AND 300 HEMAGGUTINATING UNITS OF ACCELUAR PERTUSSIS VACCINE PER EACH 0.5 ML

ACEL-IMUNE

DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE,ADSORBED,MODIFIED

NSN, MFG P/N

6505013561193

NSN

6505-01-356-1193

View More Info

ACEL-IMUNE

DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE,ADSORBED,MODIFIED

NSN, MFG P/N

6505013561193

NSN

6505-01-356-1193

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPHTHERIA & TETANUS TOXOIDS & PERTUSSIS VACCINE ABSORBED MOD 5ML
IMMEDIATE CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: CONTAINS 7.5 LF OF DIPHTHERIA TOXOID AND 5.0 LF OF TETANUS TOXOID AND 300 HEMAGGUTINATING UNITS OF ACCELUAR PERTUSSIS VACCINE PER EACH 0.5 ML

NDC00005-1800-31

DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE,ADSORBED,MODIFIED

NSN, MFG P/N

6505013561193

NSN

6505-01-356-1193

View More Info

NDC00005-1800-31

DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE,ADSORBED,MODIFIED

NSN, MFG P/N

6505013561193

NSN

6505-01-356-1193

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPHTHERIA & TETANUS TOXOIDS & PERTUSSIS VACCINE ABSORBED MOD 5ML
IMMEDIATE CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: CONTAINS 7.5 LF OF DIPHTHERIA TOXOID AND 5.0 LF OF TETANUS TOXOID AND 300 HEMAGGUTINATING UNITS OF ACCELUAR PERTUSSIS VACCINE PER EACH 0.5 ML

NDC00005-1950-31

DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE,ADSORBED,MODIFIED

NSN, MFG P/N

6505013561193

NSN

6505-01-356-1193

View More Info

NDC00005-1950-31

DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE,ADSORBED,MODIFIED

NSN, MFG P/N

6505013561193

NSN

6505-01-356-1193

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPHTHERIA & TETANUS TOXOIDS & PERTUSSIS VACCINE ABSORBED MOD 5ML
IMMEDIATE CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: CONTAINS 7.5 LF OF DIPHTHERIA TOXOID AND 5.0 LF OF TETANUS TOXOID AND 300 HEMAGGUTINATING UNITS OF ACCELUAR PERTUSSIS VACCINE PER EACH 0.5 ML

NDC49281-0298-10

DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE,ADSORBED,MODIFIED

NSN, MFG P/N

6505013561193

NSN

6505-01-356-1193

View More Info

NDC49281-0298-10

DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE,ADSORBED,MODIFIED

NSN, MFG P/N

6505013561193

NSN

6505-01-356-1193

MFG

G KURTZ INC

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPHTHERIA & TETANUS TOXOIDS & PERTUSSIS VACCINE ABSORBED MOD 5ML
IMMEDIATE CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: CONTAINS 7.5 LF OF DIPHTHERIA TOXOID AND 5.0 LF OF TETANUS TOXOID AND 300 HEMAGGUTINATING UNITS OF ACCELUAR PERTUSSIS VACCINE PER EACH 0.5 ML

JAPANESE ENCEPHALITIS

JAPANESE ENCEPHALITIS VACCINE

NSN, MFG P/N

6505013561194

NSN

6505-01-356-1194

View More Info

JAPANESE ENCEPHALITIS

JAPANESE ENCEPHALITIS VACCINE

NSN, MFG P/N

6505013561194

NSN

6505-01-356-1194

MFG

AVENTIS PASTEUR LTD

Description

III EXTERIOR CONTAINER WEIGHT: 50.00 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: JAPANESE ENCEPHALITIS VACCINE SUFFICIENT FOR 10 DOSES
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III UNIT OF ISSUE CUBE: 0.006 CUBIC FEET
IMMEDIATE CONTAINER QUANTITY: 2
IMMEDIATE CONTAINER TYPE: VIAL
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 10 DOSES AND 11 ML DILUENT
SPECIAL FEATURES: STORE BELOW 10 DEG. C; LYOPHILIZED
UNIT PACKAGE TYPE: PACKAGE

NDC49281-0680-20

JAPANESE ENCEPHALITIS VACCINE

NSN, MFG P/N

6505013561194

NSN

6505-01-356-1194

View More Info

NDC49281-0680-20

JAPANESE ENCEPHALITIS VACCINE

NSN, MFG P/N

6505013561194

NSN

6505-01-356-1194

MFG

AVENTIS PASTEUR LTD

Description

III EXTERIOR CONTAINER WEIGHT: 50.00 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: JAPANESE ENCEPHALITIS VACCINE SUFFICIENT FOR 10 DOSES
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III UNIT OF ISSUE CUBE: 0.006 CUBIC FEET
IMMEDIATE CONTAINER QUANTITY: 2
IMMEDIATE CONTAINER TYPE: VIAL
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 10 DOSES AND 11 ML DILUENT
SPECIAL FEATURES: STORE BELOW 10 DEG. C; LYOPHILIZED
UNIT PACKAGE TYPE: PACKAGE

NDC51079-0582-05

LEUCOVORIN CALCIUM TABLETS

NSN, MFG P/N

6505013563000

NSN

6505-01-356-3000

View More Info

NDC51079-0582-05

LEUCOVORIN CALCIUM TABLETS

NSN, MFG P/N

6505013563000

NSN

6505-01-356-3000

MFG

UDL LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS LEUCOVORIN CALCIUM ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: INDIVIDUALLY SEALED
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00777-3105-33

FLUOXETINE CAPSULES,USP

NSN, MFG P/N

6505013563439

NSN

6505-01-356-3439

View More Info

NDC00777-3105-33

FLUOXETINE CAPSULES,USP

NSN, MFG P/N

6505013563439

NSN

6505-01-356-3439

MFG

DISTA PRODUCTS CO DIV OF LILLY ELI AND CO

Description

(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ADMINISTRATION: ORAL
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MG FLUOXETINE HYDROCHLORIDE CAPSULES (PROZAC); 100S (10 STRIPS OF INDIVIDUALLY SEALED CAPSULES)
TOTAL PRIMARY CONTAINER QUANTITY: 10

DIPROLENE

BETAMETHASONE DIPRO

NSN, MFG P/N

6505013563850

NSN

6505-01-356-3850

View More Info

DIPROLENE

BETAMETHASONE DIPRO

NSN, MFG P/N

6505013563850

NSN

6505-01-356-3850

MFG

SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: EQUIVALENT TO 0.05% BETAMETHASONE,USP IN AN AUGMENTED WATER IN OIL EMOLLIENT GEL BASE; EQUIV TO 0.5 MG BETAMETHASONE PER GM OF GEL IN AUGMENTED GEL BASE OF PURIFIED WATER,PROPYLENE GLYCOL,CARBOMER 940,AND SODIUM HYDROXIDE; 15 GM; THERAPEUTICALLY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAMETHASONE DIPROPIONATE GEL 15GM TUBE
~1: EQUIVALENT TO SCHERING

DIPROLENE AF GEL

BETAMETHASONE DIPRO

NSN, MFG P/N

6505013563850

NSN

6505-01-356-3850

View More Info

DIPROLENE AF GEL

BETAMETHASONE DIPRO

NSN, MFG P/N

6505013563850

NSN

6505-01-356-3850

MFG

SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: EQUIVALENT TO 0.05% BETAMETHASONE,USP IN AN AUGMENTED WATER IN OIL EMOLLIENT GEL BASE; EQUIV TO 0.5 MG BETAMETHASONE PER GM OF GEL IN AUGMENTED GEL BASE OF PURIFIED WATER,PROPYLENE GLYCOL,CARBOMER 940,AND SODIUM HYDROXIDE; 15 GM; THERAPEUTICALLY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAMETHASONE DIPROPIONATE GEL 15GM TUBE
~1: EQUIVALENT TO SCHERING

NDC00085-0634-01

BETAMETHASONE DIPRO

NSN, MFG P/N

6505013563850

NSN

6505-01-356-3850

View More Info

NDC00085-0634-01

BETAMETHASONE DIPRO

NSN, MFG P/N

6505013563850

NSN

6505-01-356-3850

MFG

SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: EQUIVALENT TO 0.05% BETAMETHASONE,USP IN AN AUGMENTED WATER IN OIL EMOLLIENT GEL BASE; EQUIV TO 0.5 MG BETAMETHASONE PER GM OF GEL IN AUGMENTED GEL BASE OF PURIFIED WATER,PROPYLENE GLYCOL,CARBOMER 940,AND SODIUM HYDROXIDE; 15 GM; THERAPEUTICALLY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAMETHASONE DIPROPIONATE GEL 15GM TUBE
~1: EQUIVALENT TO SCHERING

NDC00168-0266-15

BETAMETHASONE DIPRO

NSN, MFG P/N

6505013563850

NSN

6505-01-356-3850

View More Info

NDC00168-0266-15

BETAMETHASONE DIPRO

NSN, MFG P/N

6505013563850

NSN

6505-01-356-3850

MFG

NYCOMED US INC. DIV FOUGERA/SAVAGE LABS/PHARMADERM USE CAGE CODE 60910 FOR CATALOGING.

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: EQUIVALENT TO 0.05% BETAMETHASONE,USP IN AN AUGMENTED WATER IN OIL EMOLLIENT GEL BASE; EQUIV TO 0.5 MG BETAMETHASONE PER GM OF GEL IN AUGMENTED GEL BASE OF PURIFIED WATER,PROPYLENE GLYCOL,CARBOMER 940,AND SODIUM HYDROXIDE; 15 GM; THERAPEUTICALLY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAMETHASONE DIPROPIONATE GEL 15GM TUBE
~1: EQUIVALENT TO SCHERING